These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 24460352)

  • 1. Prevalence of aflatoxin induced p53 mutation at codon 249 (R249s) in hepatocellular carcinoma patients with and without hepatitis B surface antigen (HBsAg).
    Chittmittrapap S; Chieochansin T; Chaiteerakij R; Treeprasertsuk S; Klaikaew N; Tangkijvanich P; Komolmit P; Poovorawan Y
    Asian Pac J Cancer Prev; 2013; 14(12):7675-9. PubMed ID: 24460352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus genetic variation and TP53 R249S mutation in patients with hepatocellular carcinoma in Thailand.
    Thongbai C; Sa-nguanmoo P; Kranokpiruk P; Poovorawan K; Poovorawan Y; Tangkijvanich P
    Asian Pac J Cancer Prev; 2013; 14(6):3555-9. PubMed ID: 23886144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TP53 R249S mutations, exposure to aflatoxin, and occurrence of hepatocellular carcinoma in a cohort of chronic hepatitis B virus carriers from Qidong, China.
    Szymañska K; Chen JG; Cui Y; Gong YY; Turner PC; Villar S; Wild CP; Parkin DM; Hainaut P
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1638-43. PubMed ID: 19366907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seasonal variation in TP53 R249S-mutated serum DNA with aflatoxin exposure and hepatitis B virus infection.
    Villar S; Le Roux-Goglin E; Gouas DA; Plymoth A; Ferro G; Boniol M; Lereau M; Bah E; Hall AJ; Wild CP; Mendy M; Norder H; van der Sande M; Whittle H; Friesen MD; Groopman JD; Hainaut P
    Environ Health Perspect; 2011 Nov; 119(11):1635-40. PubMed ID: 21768053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between HBX status, aflatoxin-induced R249S TP53 mutation and risk of hepatocellular carcinoma in a case-control study from Thailand.
    Ortiz-Cuaran S; Villar S; Gouas D; Ferro G; Plymoth A; Khuhaprema T; Kalalak A; Sangrajrang S; Friesen MD; Groopman JD; Hainaut P
    Cancer Lett; 2013 Apr; 331(1):46-51. PubMed ID: 23200676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan.
    Lunn RM; Zhang YJ; Wang LY; Chen CJ; Lee PH; Lee CS; Tsai WY; Santella RM
    Cancer Res; 1997 Aug; 57(16):3471-7. PubMed ID: 9270015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TP53 R249S mutation, genetic variations in HBX and risk of hepatocellular carcinoma in The Gambia.
    Gouas DA; Villar S; Ortiz-Cuaran S; Legros P; Ferro G; Kirk GD; Lesi OA; Mendy M; Bah E; Friesen MD; Groopman J; Chemin I; Hainaut P
    Carcinogenesis; 2012 Jun; 33(6):1219-24. PubMed ID: 22759751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Droplet digital PCR detects high rate of TP53 R249S mutants in cell-free DNA of middle African patients with hepatocellular carcinoma.
    Marchio A; Amougou Atsama M; Béré A; Komas NP; Noah Noah D; Atangana PJA; Camengo-Police SM; Njouom R; Bekondi C; Pineau P
    Clin Exp Med; 2018 Aug; 18(3):421-431. PubMed ID: 29749584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aflatoxin-induced TP53 R249S mutation in hepatocellular carcinoma in Thailand: association with tumors developing in the absence of liver cirrhosis.
    Villar S; Ortiz-Cuaran S; Abedi-Ardekani B; Gouas D; Nogueira da Costa A; Plymoth A; Khuhaprema T; Kalalak A; Sangrajrang S; Friesen MD; Groopman JD; Hainaut P
    PLoS One; 2012; 7(6):e37707. PubMed ID: 22675488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan.
    Shirabe K; Toshima T; Taketomi A; Taguchi K; Yoshizumi T; Uchiyama H; Harimoto N; Kajiyama K; Egashira A; Maehara Y
    Liver Int; 2011 Oct; 31(9):1366-72. PubMed ID: 21745313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure.
    Qi LN; Bai T; Chen ZS; Wu FX; Chen YY; De Xiang B; Peng T; Han ZG; Li LQ
    Liver Int; 2015 Mar; 35(3):999-1009. PubMed ID: 24461059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [p53 gene mutation in hepatocellular carcinoma].
    Jiang W; Lu Q; Pan G
    Zhonghua Wai Ke Za Zhi; 1998 Sep; 36(9):531-2. PubMed ID: 11825456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanism of hepatocarcinogenesis.
    Sheu JC
    J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S309-13. PubMed ID: 9407351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does aflatoxin B1 play a role in the etiology of hepatocellular carcinoma in the United States?
    Hoque A; Patt YZ; Yoffe B; Groopman JD; Greenblatt MS; Zhang YJ; Santella RM
    Nutr Cancer; 1999; 35(1):27-33. PubMed ID: 10624703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations of p53 gene in hepatocellular carcinoma: roles of hepatitis B virus and aflatoxin contamination in the diet.
    Hsia CC; Kleiner DE; Axiotis CA; Di Bisceglie A; Nomura AM; Stemmermann GN; Tabor E
    J Natl Cancer Inst; 1992 Nov; 84(21):1638-41. PubMed ID: 1279184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between exposure to aflatoxin, mutation in TP53, infection with hepatitis B virus, and occurrence of liver disease in a selected population in Hyderabad, India.
    Anitha S; Raghunadharao D; Waliyar F; Sudini H; Parveen M; Rao R; Kumar PL
    Mutat Res Genet Toxicol Environ Mutagen; 2014 May; 766():23-8. PubMed ID: 24657665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China.
    Ming L; Thorgeirsson SS; Gail MH; Lu P; Harris CC; Wang N; Shao Y; Wu Z; Liu G; Wang X; Sun Z
    Hepatology; 2002 Nov; 36(5):1214-20. PubMed ID: 12395332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occult hepatitis B virus infection in HBs antigen-negative hepatocellular carcinoma in a Japanese population: involvement of HBx and p53.
    Shiota G; Oyama K; Udagawa A; Tanaka K; Nomi T; Kitamura A; Tsutsumi A; Noguchi N; Takano Y; Yashima K; Kishimoto Y; Suou T; Kawasaki H
    J Med Virol; 2000 Oct; 62(2):151-8. PubMed ID: 11002243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.